Nuveen LLC Makes New Investment in Phibro Animal Health Corporation $PAHC

Nuveen LLC bought a new position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 482,773 shares of the company’s stock, valued at approximately $10,312,000. Nuveen LLC owned approximately 1.19% of Phibro Animal Health as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Phibro Animal Health by 0.4% during the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company’s stock worth $32,500,000 after purchasing an additional 6,784 shares in the last quarter. Nuveen Asset Management LLC boosted its position in Phibro Animal Health by 21.4% during the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock worth $12,348,000 after purchasing an additional 103,618 shares in the last quarter. CastleKnight Management LP boosted its position in Phibro Animal Health by 6.2% during the fourth quarter. CastleKnight Management LP now owns 389,433 shares of the company’s stock worth $8,178,000 after purchasing an additional 22,796 shares in the last quarter. Invesco Ltd. boosted its position in Phibro Animal Health by 92.3% during the first quarter. Invesco Ltd. now owns 387,739 shares of the company’s stock worth $8,282,000 after purchasing an additional 186,087 shares in the last quarter. Finally, AQR Capital Management LLC boosted its position in Phibro Animal Health by 27.8% during the fourth quarter. AQR Capital Management LLC now owns 327,418 shares of the company’s stock worth $6,876,000 after purchasing an additional 71,150 shares in the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have commented on PAHC. JPMorgan Chase & Co. upgraded Phibro Animal Health from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $25.00 to $35.00 in a research report on Monday, July 7th. BNP Paribas upgraded Phibro Animal Health to a “hold” rating in a research report on Monday, June 16th. Morgan Stanley set a $26.00 price objective on Phibro Animal Health and gave the company an “equal weight” rating in a research report on Wednesday, June 25th. Wall Street Zen upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. Finally, BNP Paribas Exane upgraded Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price objective on the stock in a research report on Monday, June 16th. One investment analyst has rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Phibro Animal Health has a consensus rating of “Reduce” and a consensus price target of $24.40.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $32.46 on Friday. The business’s 50-day moving average price is $28.31 and its 200 day moving average price is $24.11. Phibro Animal Health Corporation has a twelve month low of $16.16 and a twelve month high of $32.95. The company has a market capitalization of $1.32 billion, a PE ratio of 41.62, a price-to-earnings-growth ratio of 0.53 and a beta of 0.80. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a yield of 1.5%. Phibro Animal Health’s dividend payout ratio is 61.54%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.